Fibrolamellar Carcinoma: 2012 Update

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Syndrome</td><td align="center"> </td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Wilms [<a href="/journals/scientifica/2012/743790/#B37">51</a>]</td><td align="center"> </td></tr><tr><td align="left">Carney [<a href="/journals/scientifica/2012/743790/#B60">74</a>]</td><td align="center"> </td></tr><tr><td align="left">Fanconi anemia [<a href="/journals/scientifica/2012/743790/#B137">110</a>]</td><td align="center"> </td></tr><tr><td align="left">FAP [<a href="/journals/scientifica/2012/743790/#B138">111</a>]</td><td align="center"> </td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Reports of FLC in the setting of inherited syndromes or with other nonhepatic tumors. 

Scientifica

Fibrolamellar Carcinoma: 2012 Update

Table 3